All filters
Slidesets
Andrea Calgano - Pharmacological Considerations in Choice of Regimen
Presented at:
Chinese HIV Clinical Forum 2022
Slidesets
Wei Lyu - Clinical Case (focused on starting and switching therapy)
Presented at:
Chinese HIV Clinical Forum 2022
Slidesets
Fujie Zhang - HIV Low-Level Viremia and New Approach to Drug Resistance Surveillance
Presented at:
Chinese HIV Clinical Forum 2022
Slidesets
Marta Boffito - Stopping/Switching Considerations When Using La-ARVs
Presented at:
Chinese HIV Clinical Forum 2022
Slidesets
Pharmacology of Injectable ART & Implications for Toxicity & Resistance - Marta Boffito, MD, PhD, FRCP
Presented at:
Innovations in HIV Therapeutics - Europe/North America Edition 2022
Slidesets
The Long-Acting Pipeline for HIV Treatment - Charles Flexner, MD
Presented at:
Innovations in HIV Therapeutics - Europe/North America Edition 2022
Slidesets
Long-Acting Pipeline for HIV Prevention - Laura Waters, MD, FRCP
Presented at:
Innovations in HIV Therapeutics - Europe/North America Edition 2022
Slidesets
Implementation of Long-Acting PrEP - Adam Spivak, MD
Presented at:
Innovations in HIV Therapeutics - Europe/North America Edition 2022
Slidesets
Implementation of Innovations and How to Expand Access - David H. Brown Ripin, PhD, BS
Presented at:
Innovations in HIV Therapeutics - Europe/North America Edition 2022
Slidesets
Implant & Device Innovations Beyond ART Implication for HIV Prevention & Care - Marc Baum, BSc, PhD
Presented at:
Innovations in HIV Therapeutics - Europe/North America Edition 2022
Slidesets
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Development of Assembly Next Generation Core Inhibitors - Grace Wang
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Evidence of T Cell Restoration after siRNA Therapy - Emily Thi
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni
Presented at:
International Workshop on HBV Cure 2022
Slidesets
HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen
Presented at:
International Workshop on HBV Cure 2022
Slidesets
What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld
Presented at:
International Workshop on HBV Cure 2022
Slidesets
CON Standpoint - Laura Waters, MD, FRCP
Presented at:
2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?
Slidesets
PRO Standpoint - Jürgen Rockstroh, MD
Presented at:
2DR Debate: Should the Majority of People Living with HIV Be on a 2DR Regimen?